Prenetics Global Limited
PRE | NASDAQ
$23.07
-$1.27 (-5.22%)
Sep 22, 2026, 10:40 AM ET · Market open
Company Profile
As an investment holding company, Prenetics Global Limited specializes in providing diagnostic and genetic testing services. Its comprehensive product line features CircleDNA, a consumer-oriented genetic analysis solution, and the Circle HealthPod, an advanced health monitoring device. The Circle HealthPod facilitates rapid COVID-19 detection through nucleic acid amplification technology, suitable for both professional point-of-care and personal at-home use. Additionally, the company offers ColoClear, a non-invasive FIT-DNA screening test for colorectal cancer, and Circle SnapShot, a readily available at-home blood testing kit. Other diagnostic solutions in their portfolio include Circle Medical, Circle One, and F1x/Fem. Prenetics Global Limited was founded in 2014 and maintains its headquarters in Quarry Bay, Hong Kong.
Key Executives
| Name | Position |
|---|---|
| Sheng Wu Yeung | Co-Founder, Chairperson & Chief Executive Officer |
| Brian J. Rosin | Chief Financial Officer of U.S. |
| Brian Chae | General Counsel |
| James DiNicolantonio | Chief Nutrition Officer, Member of Scientific & Medical Advisory Board |
| Samantha Kwok | Chief of Staff & VP of People & Operations |
| Senthil Sundaram | Chief Clinical Officer |
Prenetics Global Limited
| Country | Hong Kong SAR China |
| IPO Date | Jul 15, 2021 |
| Industry | Medical - Diagnostics & Research |
| Sector | Healthcare |
| Employees | 98 |
| CEO | Sheng Wu Yeung |
Contact Details
Unit 701-706, K11 Atelier King’s Road Hong Kong Hong Kong SAR China
Stock Details
| Ticker Symbol | PRE |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0001876431 |
| CUSIP Number | G72245122 |
| ISIN Number | KYG722451229 |
| SIC Code | 3826 |
Add to Watchlist
Select watchlists to add or remove PRE